HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Mexican Carriers of the HNF1A p.E508K Variant Do Not Experience an Enhanced Response to Sulfonylureas.

AbstractOBJECTIVE:
To assess whether an ethnic-specific variant (p.E508K) in the maturity-onset diabetes of the young (MODY) gene hepatocyte nuclear factor-1α (HNF1A) found in Mexicans is associated with higher sensitivity to sulfonylureas, as documented in patients with MODY3.
RESEARCH DESIGN AND METHODS:
We recruited 96 participants (46 variant carriers and 50 age- and sex-matched noncarriers). Response to glipizide (one 2.5-5.0-mg dose), metformin (four 500-mg doses), and an oral glucose challenge was evaluated using a previously validated protocol. Glucose and insulin levels and their areas under the curve (AUCs) were compared between groups.
RESULTS:
Carriers of the p.E508K variant had a lower maximum insulin peak during the glipizide challenge as compared with noncarriers with diabetes (P < 0.05). Also, carriers had a lower insulin response after the oral glucose challenge. Following an oral glucose tolerance test in the presence of metformin, carriers of the p.E508K variant with diabetes had a lower maximum insulin peak and total and incremental insulin AUC value as compared with noncarriers with diabetes (P < 0.05). A similar but nonsignificant trend was seen in participants without type 2 diabetes.
CONCLUSIONS:
Carriers of variant p.E508K in HNF1A have a reduced insulin response rather than the increased sensitivity to sulfonylureas seen in patients with MODY3.
AuthorsAlexandro J Martagón, Omar Yaxmehen Bello-Chavolla, Olimpia Arellano-Campos, Paloma Almeda-Valdés, Geoffrey A Walford, Ivette Cruz-Bautista, Donají V Gómez-Velasco, Roopa Mehta, Liliana Muñoz-Hernández, Magdalena Sevilla-González, Tannia L Viveros-Ruiz, María Luisa Ordoñez-Sánchez, Rosario Rodríguez-Guillen, Jose C Florez, María Teresa Tusié-Luna, Carlos A Aguilar-Salinas, Slim Initiative in Genomic Medicine for the Americas (SIGMA) Type 2 Diabetes Consortium
JournalDiabetes care (Diabetes Care) Vol. 41 Issue 8 Pg. 1726-1731 (08 2018) ISSN: 1935-5548 [Electronic] United States
PMID29844095 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Copyright© 2018 by the American Diabetes Association.
Chemical References
  • HNF1A protein, human
  • Hepatocyte Nuclear Factor 1-alpha
  • Insulin
  • Sulfonylurea Compounds
Topics
  • Adolescent
  • Adult
  • Aged
  • Amino Acid Substitution
  • Case-Control Studies
  • Diabetes Mellitus, Type 2 (blood, drug therapy, ethnology, genetics)
  • Drug Resistance (genetics)
  • Female
  • Glucose Tolerance Test
  • Hepatocyte Nuclear Factor 1-alpha (genetics)
  • Heterozygote
  • Humans
  • Insulin (therapeutic use)
  • Insulin Resistance (genetics)
  • Male
  • Mexico (ethnology)
  • Middle Aged
  • Mutation, Missense
  • Polymorphism, Single Nucleotide
  • Sulfonylurea Compounds (therapeutic use)
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: